Search results
Showing results for
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
Engineering and improving anti-CTLA-4 checkpoint inhibitors.
Journal article
Galvez-Cancino F. et al, (2026), Clinical cancer research : an official journal of the American Association for Cancer Research
Immunopeptidomics-guided identification of functional neoantigens in non-small cell lung cancer.
Journal article
Nicholas B. et al, (2026), NPJ precision oncology
Ensuring vaccine cold chain integrity: A rapid and low-cost test for identifying heat-exposed sucrose-containing vaccines.
Journal article
Arman BY. et al, (2026), International journal of pharmaceutics: X, 11
Association Between Chronic Inflammation, Bone Density, and Muscle in Peripubertal Adolescents With and Without HIV in Zimbabwe: A Cross-sectional Study.
Journal article
Jeena L. et al, (2026), Open forum infectious diseases, 13
Association of Diabetes Mellitus With a Shared Hyperinflammatory Immune Response in Patients With Melioidosis and Patients With Tuberculosis: An Observational Case-Control Study.
Journal article
Rongkard P. et al, (2026), Open forum infectious diseases, 13
BOA constrictor: a Mamba-based lossless compressor for scientific data
Journal article
Gupta A. et al, (2026), Machine Learning Science and Technology, 7
Exploring the role of Indian Hedgehog in regulating immunogenicity in colorectal cancer
Thesis / Dissertation
Hasan S., (2026)
Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trial.
Journal article
Turner HC. et al, (2026), EClinicalMedicine, 95
Nonclassical MHC-I Molecules: Emerging Therapeutic Targets in Next-Generation Immunotherapy.
Journal article
He W. and McMichael AJ., (2026), MedComm, 7
HLA-E-restricted T cells primed by a modified HLA-B*57:01 restricted HIV-1 peptide suppress HIV-1 replication.
Journal article
Sun H. et al, (2026), JCI insight
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial.
Journal article
Melero I. et al, (2026), Nature cancer
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanoma.
Journal article
Garralda E. et al, (2026), Clinical cancer research : an official journal of the American Association for Cancer Research
Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF.
Journal article
Ma B. et al, (2026), Science immunology, 11
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial.
Journal article
Melero I. et al, (2026), Nature medicine
Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I
Preprint
Murali TM. et al, (2026)
Intratumoral heterogeneity and immunotherapy resistance: clinical implications.
Journal article
Keenan BP. et al, (2026), Annals of oncology : official journal of the European Society for Medical Oncology, 37, 314 - 328
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B.
Journal article
Kalafateli M. et al, (2026), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 24, 701 - 712.e8
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.
Journal article
Sanmamed MF. et al, (2026), Clinical cancer research : an official journal of the American Association for Cancer Research, 32, 1036 - 1045
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis.
Journal article
Beernaert B. et al, (2026), Science advances, 12